Ayala Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. | 01/26/2023 | 2.15 M | $862.00 K | 0.00% | 13.94% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2023 | 56.90 K | $23.94 K | -30.53% | 0.37% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2023 | 53.60 K | $21.00 K | 11.67% | 0.35% |
| PSAGOT VALUE HOLDINGS LTD. / (ISRAEL) | 01/30/2023 | 36.23 K | $14.00 K | -40.62% | 0.23% |
| TWO SIGMA SECURITIES, LLC | 02/14/2023 | 16.06 K | $6.43 K | -24.32% | 0.10% |
| MORGAN STANLEY | 02/14/2023 | 13.93 K | $5.57 K | -14.70% | 0.09% |
| CITADEL ADVISORS LLC | 02/14/2023 | 11.42 K | $4.80 K | 100.00% | 0.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 10.60 K | $4.00 K | 0.00% | 0.07% |
| AVANTAX PLANNING PARTNERS, INC. | 02/10/2023 | 10.00 K | $4.00 K | 100.00% | 0.06% |
| UBS GROUP AG | 02/08/2023 | 1.01 K | $404 | 100.00% | 0.01% |
| AMELIORA WEALTH MANAGEMENT LTD. | 02/06/2023 | 750 | $316 | 0.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 01/30/2023 | 0 | $0 | 0.00% | 0.00% |
| CSS LLC/IL | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
| CLEAR STREET LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ayala Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of Ayala Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Marshall Wace North America L.P.: 49,266
15.30% of Ayala Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 49.27 K shares in the last 24 months. This purchase volume represents approximately $26.11 K in transactions.